STOREBRAND ASSET MANAGEMENT AS
Position in NBIX — Neurocrine Biosciences Inc
CIK 1685676
LYSAKER, Q8
Position in NBIX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$76,540
-$545,526 QoQ
Shares Held
581
-86.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $76,715,400 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
93,743 | $55,587,724 | |
| 2 | ZTS |
Zoetis Inc.
|
91,260 | $10,787,844 | |
| 3 | VTRS |
Viatris Inc
|
726,652 | $9,817,068 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
17,885 | $427,988 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
581 | $76,540 | |
| 6 | HCM |
HUTCHMED (China) Ltd
|
1,219 | $18,236 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,540 | 581 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $622,066 | 4,386 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $615,706 | 4,386 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $523,121 | 4,162 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $562,401 | 5,085 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $4,816,675 | 35,287 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $11,182,331 | 97,052 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $10,803,928 | 78,477 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $10,515,986 | 76,247 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $10,163,307 | 77,135 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $12,023,212 | 106,873 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $10,139,701 | 107,526 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $13,463,575 | 133,013 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $12,192,076 | 102,077 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $721,272 | 6,791 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $661,986 | 6,791 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $636,656 | 6,791 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $619,441 | 7,273 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $697,553 | 7,273 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $1,095,141 | 11,253 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $1,094,354 | 11,253 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $2,612,200 | 27,253 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $3,035,194 | 31,564 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $1,288,808 | 10,564 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $417,430 | 4,823 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||